Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
about
Parasitic Mistletoes of the Genera Scurrula and Viscum: From Bench to BedsideViscum album (L.) in experimental animal tumors: A meta-analysis.Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cellsPlant lectins, from ancient sugar-binding proteins to emerging anti-cancer drugs in apoptosis and autophagy.Lectins with potential for anti-cancer therapy.Plant Lectins as Medical Tools against Digestive System Cancers.Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model.Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.Identification of Viscum album L. miRNAs and prediction of their medicinal values.Minor regression and long-time survival (56 months) in a patient with malignant pleural mesothelioma under Viscum album and Helleborus niger extracts—a case report.Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: A case report.Curcumin and Viscum album Extract Decrease Proliferation and Cell Viability of Soft-Tissue Sarcoma Cells: An In Vitro Analysis of Eight Cell Lines Using Real-Time Monitoring and Colorimetric Assays.Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway.Emerging roles of mistletoes in malignancy management.Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing MiceClinical Safety of Combined Targeted and L. Therapy in Oncological Patients
P2860
Q26739988-E90111AC-C615-4E8B-8777-A2793EB29A16Q33760325-29247C7F-D989-4D12-BD3F-2936E50F62EEQ36095351-AAF233C4-F866-4BAB-BC27-8F8BE374FB98Q37641834-E92EA7DA-CC5D-4CB2-BCF5-5D23C2C5ACA5Q38285464-6784DE14-9DF5-48D9-9CCE-00E78822E18CQ38366653-A7CA8090-1F88-45E7-847C-EABBE83A3781Q38696887-45301531-3BA2-4E15-B32C-D7FC1F5DFB95Q40118206-2CB6F848-87FC-4450-9A1C-72919063D685Q41634773-9881CB64-934B-4858-ADD0-E84010C14620Q47122928-B6508E9C-A346-4A1F-AFEB-5C6091A334AFQ47170177-0565A062-8888-4469-B98C-EC928F858DF7Q47277573-D7EE0385-D68C-4AED-B727-242B138EB69DQ50976238-A2DC60CE-0460-4412-9595-B2A16F5223A1Q51634430-C3842899-550F-4F07-9468-0D1F4AB9F924Q52720206-82447363-E570-44A8-91D0-F0AF948FC715Q55617959-C3F0B450-AAAD-433A-8EBC-6540FBA26655Q58700451-75A872CA-48F6-4529-9630-62B481C12D70Q58760840-EE5045C8-1EDA-4F31-BA6E-F4CC61247AF9
P2860
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@ast
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@en
type
label
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@ast
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@en
prefLabel
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@ast
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@en
P2093
P2860
P356
P1476
Fermented mistletoe extract as a multimodal antitumoral agent in gliomas.
@en
P2093
Oliver Podlech
Patrick N Harter
Simone Pöschel
Ulrike Naumann
P2860
P304
P356
10.1155/2012/501796
P577
2012-10-22T00:00:00Z